Top compounds associated with response to C19orf84


Feature Type Standardized
Nominal ANOVA
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.04 0.3
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA FQI-1 CTRPv2 pan-cancer AAC 0.05 0.3
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC -0.079 0.3
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.3
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.04 0.3
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.3
mRNA WAY-362450 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.3
Download CSV